Abstract
The presence of pulmonary hypertension (PH) may affect whether cardiac tamponade physiology develops from a pericardial effusion. Specifically, the increased intracardiac pressure and right ventricular hypertrophy associated with PH would seemingly increase the intrapericardial pressure threshold at which the right-sided chambers collapse. In this systematic review, we examined the impact of PH on the incidence, in-hospital and long-term mortality, and echocardiographic findings of patients with cardiac tamponade. Using the PRISMA guideline, a systematic search was conducted in PubMed, Academic Search Premier, Web of Science, Google Scholar, and the Cochrane Database for studies investigating PH and cardiac tamponade. The Newcastle–Ottawa Scale was used to analyze the quality of returned studies. Primary outcomes included the incidence of cardiac tamponade, as well as in-hospital and long-term mortality rates. Secondary outcomes were the presence or absence of echocardiographic findings of cardiac tamponade in patients with PH. Forty-three studies (9 cohort studies and 34 case reports) with 1054 patients were included. The incidence of cardiac tamponade was significantly higher in patients with PH compared to those without PH, 2.0% (95% CI 1.2–3.2%) vs. 0.05% (95% CI 0.05–0.05%), p < 0.0001, OR 40.76 (95% CI 24.8–66.9). The incidence of tamponade in patients with a known pericardial effusion was similar in those with and without PH, 20.3% (95% CI 12.0–32.3%) and 20.9% (95% CI 18.0–24.1%), p = 0.9267, OR 0.97 (95% CI 0.50–1.87). In patients with tamponade, those with PH demonstrated a significantly higher in-hospital mortality than those without PH, 38.8% (95% CI 26.4–52.8%) vs. 14.4% (95% CI 14.2–14.6%), p < 0.0001, OR 3.77 (95% CI 2.12–6.70). Long-term mortality in patients with tamponade was significantly lower in those with PH than in those without PH, 45.5% (95% CI 33.0–58.5%) vs. 59.1% (95% CI 54.7–63.4%), p = 0.0258, OR 0.576 (95% CI 0.33–1.01). However, after stratifying by non-malignant etiologies, the long-term mortality benefit for those with PH disappeared. In the studies that described specific echocardiographic findings of cardiac tamponade, only 10.5% of patients with PH and tamponade showed right atrial and right ventricular collapse. When evaluating patients with pericardial effusions, physicians must recognize the effects of underlying PH on the incidence, in-hospital and long-term mortality rates, and potentially atypical echocardiographic presentation of cardiac tamponade.
Similar content being viewed by others
Data availability
All data supporting the findings of this study are available within the paper and its Supplementary Information. Any additional data and calculations can be made available upon request.
References
Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M et al (2023) 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 61:2200879
Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J et al (2015) 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 36:2921–2964
Klein AL, Abbara S, Agler DA, Appleton CP, Asher CR, Hoit B et al (2013) American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr 26:965-1012.e15
Alerhand S, Adrian RJ, Long B, Avila J (2022) Pericardial tamponade: A comprehensive emergency medicine and echocardiography review. Am J Emerg Med 58:159–174
Dragoi L, Teijeiro-Paradis R, Douflé G (2022) When is tamponade not an echocardiographic diagnosis… Or is it ever? Echocardiography 39:880–885
Alerhand S, Carter JM (2019) What echocardiographic findings suggest a pericardial effusion is causing tamponade? Am J Emerg Med 37:321–326
Ferguson MA (2015) Commentary on “protective effect of pulmonary hypertension against right-sided tamponade in pericardial effusion.” South Med J 108:49–50
Khan MU, Khouzam RN (2015) Protective effect of pulmonary hypertension against right-sided tamponade in pericardial effusion. South Med J 108:46–48
Sahay S, Tonelli AR (2013) Pericardial effusion in pulmonary arterial hypertension. Pulm Circ 3:467–477
Arnott C, Cordina R, Celermajer DS (2018) The echocardiographic characteristics and prognostic significance of pericardial effusions in Eisenmenger syndrome. Heart Lung Circ 27:394–396
Batal O, Dardari Z, Costabile C, Gorcsan J, Arena VC, Mathier MA (2015) Prognostic value of pericardial effusion on serial echocardiograms in pulmonary arterial hypertension. Echocardiography 32:1471–1476
Fenstad ER, Le RJ, Sinak LJ, Maradit-Kremers H, Ammash NM, Ayalew AM et al (2013) Pericardial effusions in pulmonary arterial hypertension: characteristics, prognosis, and role of drainage. Chest 144:1530–1538
Shimony A, Fox BD, Langleben D, Rudski LG (2013) Incidence and significance of pericardial effusion in patients with pulmonary arterial hypertension. Can J Cardiol 29:678–682
Masuyama J, Yoshio T, Takeda A, Shiina A, Kano S (1993) Long-term retrospective study of patients with connective tissue diseases accompanied by pulmonary hypertension. Ryumachi 33:29–36
Agha RA, Franchi T, Sohrabi C, Mathew G, Kerwan A, SCARE Group. The SCARE (2020) guideline: Updating consensus surgical CAse REport (SCARE) guidelines. Int J Surg 2020(84):226–230
Baragé A, Harouna Idrissa S, Mahoungou-Mackonia N, Arous S, Bennouna G, Azzouzi L et al (2021) Cardiac tamponade: Better prognosis in association with pulmonary embolism: case report. Ann Med Surg (Lond) 66:102410
Akinci SB, Gaine SP, Post W, Merrit WT, Tan HP, Winters B (2002) Cardiac tamponade in an orthotopic liver recipient with pulmonary hypertension. Crit Care Med 30:699–701
Poorsattar SP, Maus TM (2020) Isolated left-sided heart tamponade on echocardiography in severe pulmonary hypertension and right heart failure. J Cardiothorac Vasc Anesth 34:3172–3174
Paulraj S, Raj V, Ashok Kumar P, Voelker R, Smulyan H (2020) Atypical cardiac tamponade manifesting as left ventricular diastolic collapse: a case report. Cureus 12:e8045
Shadrin IY, Idossa D, Walston V, Lee J 3rd, Issa M (2020) Pulmonary hypertension and pericardial effusions-to tap or not to tap. Am J Med 133:e149–e150
Adams JR, Tonelli AR, Rokadia HK, Duggal A (2015) Cardiac tamponade in severe pulmonary hypertension. A therapeutic challenge revisited. Ann Am Thorac Soc. 12:455–460
Vallabhajosyula S, Sundaragiri PR (2015) Atypical cardiac tamponade in severe pulmonary hypertension. BMJ Case Rep. https://doi.org/10.1136/bcr-2014-209187
Singh V, Dwivedi SK, Chandra S, Sanguri R, Saran RK (2014) Isolated left ventricular diastolic collapse in pericardial tamponade: an uncommon echocardiographic finding. Echocardiography 31:E200–E203
Bibas L, Al-Kalbani M, de Perrot M, Douflé G (2019) Cardiac tamponade after pulmonary endarterectomy: mind the left side…. Eur Heart J 40:1575
Mars T, Mikolavcic H, Salobir B, Podbregar M (2010) Echocardiography of isolated subacute left heart tamponade in a patient with cor pulmonale and circumferential pericardial effusion. Cardiovasc Ultrasound 8:27
Aqel RA, Aljaroudi W, Hage FG, Tallaj J, Rayburn B, Nanda NC (2008) Left ventricular collapse secondary to pericardial effusion treated with pericardicentesis and percutaneous pericardiotomy in severe pulmonary hypertension. Echocardiography 25:658–661
Nguyen Ba V, Debien B, Villevieille T, Quiniou G, Pollet L, Lenoir B et al (2003) Pulmonary embolism to the rescue in cardiac tamponade. Ann Fr Anesth Reanim 22:896–899
Lee RT, Bhatia SJ, Kirshenbaum JM, Friedman PL (1989) Left ventricular tamponade: echocardiographic and hemodynamic manifestations. Clin Cardiol 12:102–104
Frey MJ, Berko B, Palevsky H, Hirshfeld JW Jr, Herrmann HC (1989) Recognition of cardiac tamponade in the presence of severe pulmonary hypertension. Ann Intern Med 111:615–617
Singh S, Wann LS, Schuchard GH, Klopfenstein HS, Leimgruber PP, Keelan MH Jr et al (1984) Right ventricular and right atrial collapse in patients with cardiac tamponade: a combined echocardiographic and hemodynamic study. Circulation 70:966–971
Grenader T, Shavit L (2004) Intravenous immunoglobulin in treatment of cardiac tamponade in a patient with systemic lupus erythematosus. Clin Rheumatol 23:530–532
Çilingiroğlu M, Akkuş N, Sethi S, Modi KA (2012) Large pericardial effusion induced by minoxidil. Turk Kardiyol Dern Ars 40:255–258
Alzahrani AM, Alqahtani AS, Alnajashi KS, Idrees MM (2014) Complete resolution of chronic pericardial effusion with an intensive course of inhaled iloprost in an adult patient with unrepaired ventricular septal defect, and life-threatening severe pulmonary arterial hypertension. Saudi Med J 35:1257–1259
Akhbour S, Khennine BA, Oukerraj L, Zarzur J, Cherti M (2014) Pericardial tamponade and coexisting pulmonary embolism as first manifestation of non-advanced lung adenocarcinoma. Pan Afr Med J 18:15
Moniz P, Rei D, Rodrigues J, Botella A (2018) Systemic sclerosis: severe pulmonary arterial hypertension and pericardial effusion at diagnosis. BMJ Case Rep. https://doi.org/10.1136/bcr-2017-223972
Malahfji M, Arain S (2018) Reversed pulsus paradoxus in right ventricular failure. Methodist Debakey Cardiovasc J 14:298–300
Poorsattar SP, Maus TM (2021) Isolated left heart tamponade on echocardiography in severe pulmonary hypertension and right heart failure. J Cardiothorac Vasc Anesth 35:977–978
Abrams H, Mankidy B, Simpson L, Nair A, Duncan M (2018) Pericardial effusion with cardiac tamponade and severe pulmonary arterial hypertension as an initial presentation of primary sjogren syndrome. Chest 154:914A
Venkatesh P, Gordin J, Anousheh R, Aksoy O (2019) Successful diagnosis and treatment of isolated left sided cardiac tamponade in a patient with severe pulmonary hypertension using invasive hemodynamic assessment. J Am Coll Cardiol 73:2506
Ruopp NF, Schoenberg NC, Farber HW (2019) Swan-Ganz and pericardial pressure-guided pericardiocentesis in pulmonary arterial hypertension-associated cardiac tamponade. Ann Am Thorac Soc 16:1189–1191
Lacharite-Roberge A-S, Vaidya A, Bashir R (2020) A case of clinical tamponade obscuring acute right ventricular failure and pulmonary hypertension. B54. Pulmonary hypertension associated with drugs; cancer therapies and other unusual diseases: clinical studies and case reports. Am Thorac Soc. 201:A3757
Pasricha V, Kaur NA, Laothamatas K, Bhardwaj A, Gorman D, Hira N et al (2019) Pulmonary hypertension and cardiac tamponade: a hemodynamic challenge. A54. Case reports in pulmonary vascular medicine. Am Thorac Soc. 199:A1927
Saraschandra V, Swapna K, Pranathi S, Venkata A (2014) Management of cardiac tamponade in severe pulmonary hypertension. Chest. 146:881A
Alkhawam H, Muskula PR, Effat M, Rahman S, Elwing J, Helmy T (2019) Slow and steady wins the race: management of pericardial tamponade in the setting of pulmonary hypertension. J Am Coll Cardiol 73:2843
Sauza-Sosa JC, Espinola-Zavaleta N (2017) Left atrial and left ventricular collapse secondary to pericardial effusion. J Echocardiogr 15:194–195
Tamponade EP, Havranek MD, Bailey WM, Adair OV (1993) Left Ventricular Diastolic Collapse in the Absence of Cardiac. Denver General Hospital, Denver
Amano M, Izumi C, Baba M, Abe R, Matsutani H, Nishimura S et al (2020) Occurrence of right ventricular dysfunction immediately after pericardiocentesis. Heart Vessels 35:69–77
Pradhan R, Okabe T, Yoshida K, Angouras DC, DeCaro MV, Marhefka GD (2015) Patient characteristics and predictors of mortality associated with pericardial decompression syndrome: a comprehensive analysis of published cases. Eur Heart J Acute Cardiovasc Care 4:113–120
Kumar B, Kodliwadmath A, Singh A, Upadhyay A, Darbari A, Duggal B (2021) Left ventricular tamponade- pathophysiology determines the therapeutic approach: a case series. Eur Heart J Case Rep 5:502
Krikorian JG, Hancock EW (1978) Pericardiocentesis. Am J Med 65:808–814
Nafsi T, Bopanna S, Vedavalli A, Al-Nassir K, Tandon R (2011) Pericardial effusion in pulmonary arterial hypertension. To drain or not? Chest. 140:178A
Hemnes AR, Gaine SP, Wiener CM (2008) Poor outcomes associated with drainage of pericardial effusions in patients with pulmonary arterial hypertension. South Med J 101:490–494
Liang MH, Stern S, Fortin PR, Louie DC, Marsh JD, Mudge GH Jr et al (1991) Fatal pulmonary venoocclusive disease secondary to a generalized venulopathy: a new syndrome presenting with facial swelling and pericardial tamponade. Arthritis Rheum 34:228–233
Roberts WC, Fredrickson DS (1967) Gaucher’s disease of the lung causing severe pulmonary hypertension with associated acute recurrent pericarditis. Circulation 35:783–789
Srock K, Kerr LD, Poon M, Fallon JT (2003) Refractory pulmonary hypertension in a lupus patient with occult pulmonary vasculitis. J Clin Rheumatol 9:263–266
Dunne JV, Chou JP, Viswanathan M, Wilcox P, Huang SH (2011) Cardiac tamponade and large pericardial effusions in systemic sclerosis: a report of four cases and a review of the literature. Clin Rheumatol 30:433–438
Ansari Aval Z, Mirhosseini SM, Jafari NS (2021) Atypical presentation of cardiac tamponade in pulmonary hypertension: a case report and review of the literature. Clin Case Rep 9:e05218
Liou M, Adawi RL, Rosen M, Diep J (2005) Biventricular failure post tamponade drainage in a patient with systemic lupus erythematosus and pulmonary hypertension. Chest 128:461S
Douen A, Panetti R, Mbolu G, Damania D, Apergis G, Krishnan P (2021) Cardiac tamponade without characteristic echocardiographic features due to high right heart pressure from pulmonary hypertension. Chest 160:A863
Vinter O, Trbusic M, Menegoni M (2020) Isolated left ventricular tamponade in a patient with severe pulmonary hypertension due to chronic thromboembolisms: a case report. Eur Heart J Cardiovasc Imaging. https://doi.org/10.1093/ehjci/jez319.390
Pérez-Casares A, Cesar S, Brunet-Garcia L, Sanchez-de-Toledo J (2017) Echocardiographic evaluation of pericardial effusion and cardiac tamponade. Front Pediatr 5:79
Guntheroth WG (2007) Sensitivity and specificity of echocardiographic evidence of tamponade: implications for ventricular interdependence and pulsus paradoxus. Pediatr Cardiol 28:358–362
Mercé J, Sagristà-Sauleda J, Permanyer-Miralda G, Evangelista A, Soler-Soler J (1999) Correlation between clinical and Doppler echocardiographic findings in patients with moderate and large pericardial effusion: implications for the diagnosis of cardiac tamponade. Am Heart J 138:759–764
Gillam LD, Guyer DE, Gibson TC, King ME, Marshall JE, Weyman AE (1983) Hydrodynamic compression of the right atrium: a new echocardiographic sign of cardiac tamponade. Circulation 68:294–301
Kronzon I, Cohen ML, Winer HE (1983) Diastolic atrial compression: a sensitive echocardiographic sign of cardiac tamponade. J Am Coll Cardiol 2:770–775
Fast J, Wielenga RP, Jansen E, Schuurmans Stekhoven JH (1986) Abnormal wall movements of the right ventricle and both atria in patients with pericardial effusion as indicators of cardiac tamponade. Eur Heart J 7:431–436
Materazzo C, Piotti P, Meazza R, Pellegrini MP, Viggiano V, Biasi S (2003) Respiratory changes in transvalvular flow velocities versus two-dimensional echocardiographic findings in the diagnosis of cardiac tamponade. Ital Heart J 4:186–192
Field LC, Guldan GJ 3rd, Finley AC (2011) Echocardiography in the intensive care unit. Semin Cardiothorac Vasc Anesth 15:25–39
Armstrong WF, Schilt BF, Helper DJ, Dillon JC, Feigenbaum H (1982) Diastolic collapse of the right ventricle with cardiac tamponade: an echocardiographic study. Circulation 65:1491–1496
Engel PJ, Hon H, Fowler NO, Plummer S (1982) Echocardiographic study of right ventricular wall motion in cardiac tamponade. Am J Cardiol 50:1018–1021
Singh S, Wann LS, Klopfenstein HS, Hartz A, Brooks HL (1986) Usefulness of right ventricular diastolic collapse in diagnosing cardiac tamponade and comparison to pulsus paradoxus. Am J Cardiol 57:652–656
Alagona P Jr (1983) RV compression versus transient RV free wall collapse in diagnosing cardiac tamponade. Circulation 67:706–707
Eisenberg MJ, Oken K, Guerrero S, Saniei MA, Schiller NB (1992) Prognostic value of echocardiography in hospitalized patients with pericardial effusion. Am J Cardiol 70:934–939
Gaffney FA, Keller AM, Peshock RM, Lin JC, Firth BG (1984) Pathophysiologic mechanisms of cardiac tamponade and pulsus alternans shown by echocardiography. Am J Cardiol 53:1662–1666
Gollapudi RR, Yeager M, Johnson AD (2005) Left ventricular cardiac tamponade in the setting of cor pulmonale and circumferential pericardial effusion. Case report and review of the literature. Cardiol Rev. 13:214–217
Perez PC, Galvan Roman F, Escribano SP (2020) Taponamiento cardiaco inverso en hipertensión pulmonar grave. Med Clin (Barc) 154:287
Kandasamy VV, Kaja A, Wichman TO (2014) The dilemma of management of cardiac tamponade in the presence of severe pulmonary hypertension: our experience. J Gen Intern 29:S446
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 62:1006–1012
Zeng X, Zhang Y, Kwong JSW, Zhang C, Li S, Sun F et al (2015) The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med 8:2–10
Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M et al (2023) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa hospital research institute, Ottawa
Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605
Hartling L, Hamm M, Milne A, Vandermeer B, Ansari M, Tsertsvadze A et al (2012) Reliability and validity of the Newcastle Ottawa Scale. Abstracts of the 20th Cochrane Colloquium. Wiley, Auckland
Higgins JPT, Green S (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration, London
Newcombe RG (1998) Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med 17:873–890
Wilson EB (1927) Probable inference, the law of succession, and statistical inference. J Am Stat Assoc 22:209
Artaud-Macari E, Montani D, Mercier O, Persichini R, Günther S, Jaïs X et al (2013) Characteristics and outcome of patients with pre-capillary pulmonary hypertension who were drained for tamponade: a monocentric study. Eur Respir J 42:P3412
Honeycutt GR, Safdar Z (2013) Pulmonary hypertension complicated by pericardial effusion: a single center experience. Ther Adv Respir Dis 7:151–159
Hosoya H, Derk CT (2018) Clinically symptomatic pericardial effusions in hospitalized systemic sclerosis patients: demographics and management. Biomed Res Int 2018:6812082
Chaachoui N, Haik W, Tournoux F (2011) Pulmonary artery sarcoma: a rare cause of dyspnoea. Eur J Echocardiogr 12:E20
Ushakumari DS, Alfirevic A, Sale S (2015) Acute drainage of pericardial effusion may precipitate right ventricular failure. J Cardiothorac Vasc Anesth 29:1610–1613
Sagristà-Sauleda J, Mercé J, Permanyer-Miralda G, Soler-Soler J (2000) Clinical clues to the causes of large pericardial effusions. Am J Med 109:95–101
Al-Ogaili A, Ayoub A, Fugar S, Kolkailah A, Rios LP, Fuentes H (2018) Cardiac tamponade incidence, demographics and in-hospital outcomes: analysis of the national inpatient sample database. J Am Coll Cardiol 71:A1155
Mercé J, Sagristà-Sauleda J, Permanyer-Miralda G, Soler-Soler J (1998) Should pericardial drainage be performed routinely in patients who have a large pericardial effusion without tamponade? Am J Med 105:106–109
Sagristà-Sauleda J, Angel J, Permanyer-Miralda G, Soler-Soler J (1999) Long-term follow-up of idiopathic chronic pericardial effusion. N Engl J Med 341:2054–2059
Imazio M, Lazaros G, Valenti A, De Carlini CC, Maggiolini S, Pivetta E et al (2019) Outcomes of idiopathic chronic large pericardial effusion. Heart 105:477–481
Lazaros G, Antonopoulos AS, Lazarou E, Vlachopoulos C, Foukarakis E, Androulakis A et al (2020) Long-term outcome of pericardial drainage in cases of chronic, large, hemodynamically insignificant, C-reactive protein negative, idiopathic pericardial effusions. Am J Cardiol 126:89–93
Kabukcu M, Demircioglu F, Yanik E, Basarici I, Ersel F (2004) Pericardial tamponade and large pericardial effusions: causal factors and efficacy of percutaneous catheter drainage in 50 patients. Tex Heart Inst J 31:398–403
Cornily J-C, Pennec P-Y, Castellant P, Bezon E, Le Gal G, Gilard M et al (2008) Cardiac tamponade in medical patients: a 10-year follow-up survey. Cardiology 111:197–201
Orbach A, Schliamser JE, Flugelman MY, Zafrir B (2016) Contemporary evaluation of the causes of cardiac tamponade: acute and long-term outcomes. Cardiol J 23:57–63
Sánchez-Enrique C, Nuñez-Gil IJ, Viana-Tejedor A, De Agustín A, Vivas D, Palacios-Rubio J et al (2016) Cause and long-term outcome of cardiac tamponade. Am J Cardiol 117:664–669
Adamczyk M, Wasilewski J, Niedziela JT, Zembala MO, Gąsior M (2021) Baseline characteristics, management and long-term outcomes of different etiologies of cardiac tamponade evaluated in a cohort of 340 patients. Kardiochir Torakochirurgia Pol 18:216–220
Gong W, Nie S (2021) New clinical classification for ventricular free wall rupture following acute myocardial infarction. Cardiovasc Ther 2021:1716546
Sanmartín-Fernández M, Raposeiras-Roubin S, Anguita-Sánchez M, Marín F, Garcia-Marquez M, Fernández-Pérez C et al (2021) In-hospital outcomes of mechanical complications in acute myocardial infarction: Analysis from a nationwide Spanish database. Cardiol J 28:589–597
Ma W, Liu J, Zeng Y, Chen S, Zheng Y, Ye S et al (2012) Causes of moderate to large pericardial effusion requiring pericardiocentesis in 140 Han Chinese patients. Herz 37:183–187
Kızıltunç E, Ünlü S, Yakıcı İE, Kundi H, Korkmaz A, Çetin M et al (2020) Clinical characteristics and prognosis of cardiac tamponade patients: 5-year experience at a tertiary center. Herz 45:676–683
Ristić AD, Imazio M, Adler Y, Anastasakis A, Badano LP, Brucato A et al (2014) Triage strategy for urgent management of cardiac tamponade: a position statement of the European society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 35:2279–2284
Eke OF, Selame L, Gullikson J, Deng H, Dutta S, Shokoohi H (2022) Timing of pericardiocentesis and clinical outcomes: is earlier pericardiocentesis better? Am J Emerg Med 54:202–207
Sinnaeve PR, Adriaenssens T (2019) A contemporary look at pericardiocentesis. Trends Cardiovasc Med 29:375–383
Sunday R, Robinson LA, Bosek V (1999) Low cardiac output complicating pericardiectomy for pericardial tamponade. Ann Thorac Surg 67:228–231
Armstrong WF, Feigenbaum H, Dillon JC (1984) Acute right ventricular dilation and echocardiographic volume overload following pericardiocentesis for relief of cardiac tamponade. Am Heart J 107:1266–1270
Geffroy A, Beloeil H, Bouvier E, Chaumeil A, Albaladejo P, Marty J (2004) Prolonged right ventricular failure after relief of cardiac tamponade. Can J Anaesth 51:482–485
Ghio S, Temporelli PL, Klersy C, Simioniuc A, Girardi B, Scelsi L et al (2013) Prognostic relevance of a non-invasive evaluation of right ventricular function and pulmonary artery pressure in patients with chronic heart failure. Eur J Heart Fail 15:408–414
Harada D, Asanoi H, Noto T, Takagawa J (2020) The impact of right ventricular dysfunction on the effectiveness of beta-blockers in heart failure with preserved ejection fraction. J Cardiol 76:325–334
Acknowledgements
None.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Robert James Adrian, Stephen Alerhand, Andrew Liteplo, and Hamid Shokoohi. The first draft of the manuscript was written by Robert James Adrian and Stephen Alerhand and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
None.
Ethical approval
This systematic review adheres to the ethical guidelines outlined in the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement.
Human and animal rights
As this systematic review involves the synthesis of data from previously published studies, no direct involvement of human or animal subjects occurred during this research, therefore the study was exempt from IRB systematic reviews. No studies were reported involving animal subjects in their studies.
Informed consent
Considering the established ethical guidelines, all included studies in this systematic review obtained appropriate ethical approval and informed consent from human participants, where applicable, as detailed by the original authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendices
Appendix 1. Search strategy
Pubmed: 101
((((("pulmonary hypertension" or "pulmonary arterial hypertension" or “cor pulmonale”) AND ("cardiac Tamponade" OR "pericardial tamponade" OR "tamponade" OR "atypical tamponade")) NOT (child)) NOT (children)) NOT (neonate)) NOT (dissection).
Academic Search Premier: 45
AB pulmonary hypertension AND AB tamponade.
Google Scholar: 29
Allintitle: tamponade pulmonary hypertension -child -neonate -children -pediatric -pediatrics -dissection.
Web of Science:109
((ALL = ("tamponade") AND ALL = ("pulmonary hypertension")) OR (ALL = ("tamponade") AND ALL = ("pulmonary arterial hypertension")) OR ALL = ("tamponade") AND (ALL = ("tamponade") AND ALL = ("cor pulmonale"))) NOT ALL = (child) NOT ALL = (juvenile) NOT ALL = (neonate) NOT ALL = (dissection) NOT ALL = children.
Cochrane Library Database
(Pulmonary hypertension):ti,ab,kw AND (tamponade):ti,ab,kw.
Cochrane Reviews: 0
Cochrane Protocols: 0
Trials: 11
Editorials: 0
Appendix 2
Newcastle–Ottawa Scale assessing quality of cohort studies
Cohort studies | Selection (maximum of 4) | Comparability (maximum of 2) | Outcome (maximum of 3) | Total (maximum of 9) |
---|---|---|---|---|
Krikorian, 1978 [50] | 3 | 0 | 3 | 6 |
Masuyama, 1993 [14] | 2 | 1 | 2 | 5 |
Hemnes, 2008 [52] | 4 | 0 | 3 | 7 |
Artaud-Macari, 2013 [86] | 1 | 0 | 1 | 2 |
Fenstad, 2013 [12] | 4 | 1 | 3 | 8 |
Honeycutt, 2013 [87] | 3 | 0 | 3 | 6 |
Shimony, 2013 [13] | 4 | 0 | 3 | 7 |
Arnott, 2018 [10] | 3 | 0 | 3 | 6 |
Hosoya, 2018 [88] | 3 | 0 | 3 | 6 |
Appendix 3
Echocardiography of patients from case reports with PH and cardiac tamponade
Study | RAC | RVC | IVCP | IRV | LAC | LVC |
---|---|---|---|---|---|---|
Akinci, 2002 [17] | ns | – | ns | ns | ns | – |
Gollapudi, 2005 [75] | ns | – | + | ns | ns | + |
Liou, 2005 [58] | ns | – | ns | + | ns | – |
Aqel, 2008 [26] | ns | – | ns | ns | ns | + |
Mars, 2010 [25] | – | – | + | ns | + | + |
Dunne, 2011 [56] | 50% | 25% | 25% | 25% | 25% | 25% |
Nafsi, 2011 [51] | – | – | ns, but “no tamponade physiology” | |||
Çilingiroğlu, 2012 [32] | – | – | – | – | ns | – |
Fenstad, 2013 [12] | 36% | 0% | ns | 100% | 57% | ns |
Singh, 2014 [23] | – | – | ns | ns | ns | + |
Adams, 2015 [21] | – | – | + | + | + | – |
Alzahrani, 2014 [33] | ns, but “no signs of tamponade” | |||||
Kandasamy, 2014 [77] | ns | – | ns | ns | + | + |
Ushakumari, 2015 [90] | + | + | ns | ns | ns | – |
Vallabhajosyula, 2015 [22] | – | – | + | + | + | ns |
Malahfji, 2018 [36] | – | – | ns | + | ns | ns |
Bibas, 2019 [24] | – | – | ns | ns | ns | + |
Ruopp, 2019 [40] | + | + | ns | ns | ns | ns |
Venkatesh, 2019 [39] | ns, but “no echocardiographic evidence of tamponade” | |||||
Kumar, 2020 [49] | – | – | ns | ns | ns | + |
Paulraj, 2020 [19] | – | – | + | + | + | ns |
Perez, 2020 [76] | – | – | ns | ns | + /LHC | + /LHC |
Poorsattar, 2020 [18] | – | – | ns | + | + | + |
Vinter, 2020 [60] | – | – | ns | + | ns | + |
Shadrin, 2020 [20] | ns, but “no signs” | |||||
Aval, 2021 [57] | ns | – | + | ns | + | + |
Baragé, 2021 [16] | ns | – | + | ns | + | + |
Duoen, 2021 [59] | – | – | ns | + | ns | ns |
Appendix 4
Are patients with PH protected from the development of cardiac tamponade or its associated mortality?
Outcome | Patients with PH (%) | Patients without PH (%) | Significance | Odds ratio | Are patients with PH protected? |
---|---|---|---|---|---|
Incidence of tamponade (no known pericardial effusion) | 2.0 | 0.05 | p < 0.0001 | 40.76 | No |
Incidence of tamponade (known pericardial effusions) | 20.3 | 20.9 | p = 0.9267 | 0.97 | No |
In-hospital mortality | 38.8 | 14.4 | p < 0.0001 | 3.77 | No |
Long-term mortality | 45.5 | 59.1 | p = 0.0258 | 0.58 | Yes* |
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Adrian, R.J., Alerhand, S., Liteplo, A. et al. Is pulmonary hypertension protective against cardiac tamponade? A systematic review. Intern Emerg Med (2024). https://doi.org/10.1007/s11739-024-03566-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11739-024-03566-y